Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Using high-throughput SNP technologies to study cancer

Abstract

Identifying genes involved in the development of cancer is crucial to fully understanding cancer biology, for developing novel therapeutics for cancer treatment and for providing methods for cancer prevention and early diagnosis. The use of polymorphic markers, in particular single nucleotide polymorphisms (SNPs), promises to provide a comprehensive tool for analysing the human genome and identifying those genes and genomic regions contributing to the cancer phenotype. This review summarizes the various analytical methodologies in which SNPs are used and presents examples of how each of these methodologies have been used to locate genes and genomic regions of interest for various cancer types. Additionally many of the current SNP-analysing technologies will be reviewed with particular attention paid to the advantages and disadvantages of each and how each technology can be applied to the analysis of the genome for identifying cancer-related genes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Avi-Itzhak HI, Su X, De La Vega FM . (2003). Pac Symp Biocomput, 466–477.

  • Badano JL, Katsanis N . (2002). Nat Rev Genet 3: 779–789.

  • Bell PA, Chaturvedi S, Gelfand CA, Huang CY, Kochersperger M, Kopla R et al. (2002). Biotechniques 32 (Suppl), 70–72, 74, 76–77.

  • Botstein D, Risch N . (2003). Nat Genet 33 (Suppl): 228–237.

  • Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N et al. (1999). Nat Genet 22: 231–238.

  • Carlini LE, Meropol NJ, Bever J, Andria ML, Hill T, Gold P et al. (2005). Clin Cancer Res 11: 1226–1236.

  • Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA . (2004). Am J Hum Genet 74: 106–120.

  • Chen J, Gammon MD, Chan W, Palomeque C, Wetmur JG, Kabat GC et al. (2005). Cancer Res 65: 1606–1614.

  • Cvetkovic D, Pisarcik D, Lee C, Hamilton TC, Abdollahi A . (2004). Gynecol Oncol 95: 449–455.

  • Dean FB, Hosono S, Fang L, Wu X, Faruqi AF, Bray-Ward P et al. (2002). Proc Natl Acad Sci USA 99: 5261–5266.

  • Emahazion T, Feuk L, Jobs M, Sawyer SL, Fredman D, St Clair D et al. (2001). Trends Genet 17: 407–413.

  • Freedman ML, Penney KL, Stram DO, Le Marchand L, Hirschhorn JN, Kolonel LN et al. (2004). Hum Mol Genet 13: 2431–2441.

  • Freedman ML, Penney KL, Stram DO, Riley S, McKean-Cowdin R, Le Marchand L et al. (2005). Cancer Res 65: 7516–7522.

  • Garraway LA, Widlund HR, Rubin MA, Getz G, Berger AJ, Ramaswamy S et al. (2005). Nature 436: 117–122.

  • Geesaman BJ, Benson E, Brewster SJ, Kunkel LM, Blanche H, Thomas G et al. (2003). Proc Natl Acad Sci USA 100: 14115–14120.

  • Gershoni-Baruch R, Dagan E, Israeli D, Kasinetz L, Kadouri E, Friedman E . (2000). Eur J Cancer 36: 2313–2316.

  • Gissen P, Johnson CA, Morgan NV, Stapelbroek JM, Forshew T, Cooper WN et al. (2004). Nat Genet 36: 400–404.

  • Graziano F, Kawakami K, Ruzzo A, Watanabe G, Santini D, Pizzagalli F et al. (2006). Int J Cancer 118: 628–632.

  • Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS . (2005). Nat Genet 37: 549–554.

  • Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D et al. (2003). Hum Mol Genet 12: 2679–2692.

  • Halldorsson BV, Bafna V, Lippert R, Schwartz R, De La Vega FM, Clark AG et al. (2004). Genome Res 14: 1633–1640.

  • Han J, Colditz GA, Samson LD, Hunter DJ . (2004a). Cancer Res 64: 3009–3013.

  • Han J, Hankinson SE, Colditz GA, Hunter DJ . (2004b). Br J Cancer 91: 1604–1609.

  • Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G et al. (2004). Cancer Res 64: 4378–4384.

  • Herr A, Grutzmann R, Matthaei A, Artelt J, Schrock E, Rump A et al. (2005). Genomics 85: 392–400.

  • Hinds DA, Stokowski RP, Patil N, Konvicka K, Kershenobich D, Cox DR et al. (2004). Am J Hum Genet 74: 317–325.

  • Hu N, Wang C, Hu Y, Yang HH, Giffen C, Tang ZZ et al. (2005a). Cancer Res 65: 2542–2546.

  • Hu Z, Huo X, Lu D, Qian J, Zhou J, Chen Y et al. (2005b). Clin Cancer Res 11: 5433–5439.

  • Huang J, Wei W, Zhang J, Liu G, Bignell GR, Stratton MR et al. (2004). Hum Genom 1: 287–299.

  • Irving JA, Bloodworth L, Bown NP, Case MC, Hogarth LA, Hall AG . (2005). Cancer Res 65: 3053–3058.

  • Ishikawa S, Komura D, Tsuji S, Nishimura K, Yamamoto S, Panda B et al. (2005). Biochem Biophys Res Commun 333: 1309–1314.

  • Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB . (2005). Am J Hum Genet 77: 389–407.

  • Janecke AR, Thompson DA, Utermann G, Becker C, Hubner CA, Schmid E et al. (2004). Nat Genet 36: 850–854.

  • Janne PA, Li C, Zhao X, Girard L, Chen TH, Minna J et al. (2004). Oncogene 23: 2716–2726.

  • Jiang Q, Chen K, Ma X, Li Q, Yu W, Shu G et al. (2005). Cancer Detect Prev 29: 146–154.

  • John S, Shephard N, Liu G, Zeggini E, Cao M, Chen W et al. (2004). Am J Hum Genet 75: 54–64.

  • Jordan B, Charest A, Dowd JF, Blumenstiel JP, Yeh Rf RF, Osman A et al. (2002). Proc Natl Acad Sci USA 99: 2942–2947.

  • Ju H, Lee KA, Yang M, Kim HJ, Kang CP, Sohn TS et al. (2005). Int J Cancer 117: 957–960.

  • Kennedy GC, Matsuzaki H, Dong S, Liu WM, Huang J, Liu G et al. (2003). Nat Biotechnol 21: 1233–1237.

  • Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C et al. (2005). Science 308: 385–389.

  • Koed K, Wiuf C, Christensen LL, Wikman FP, Zieger K, Moller K et al. (2005). Cancer Res 65: 34–45.

  • Kono S, Chen K . (2005). Cancer Sci 96: 535–542.

  • Koppert LB, van der Velden AW, van de Wetering M, Abbou M, van den Ouweland AM, Tilanus HW et al. (2004). Br J Cancer 90: 892–899.

  • Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Moghrabi A et al. (2004). Blood 103: 252–257.

  • Landegren U, Kaiser R, Sanders J, Hood L . (1988). Science 241: 1077–1080.

  • Larson GP, Ding Y, Cheng LS, Lundberg C, Gagalang V, Rivas G et al. (2005). Cancer Res 65: 805–814.

  • Li D, Ahmed M, Li Y, Jiao L, Chou TH, Wolff RA et al. (2005). Cancer Epidemiol Biomarkers Prev 14: 1470–1476.

  • Lieberfarb ME, Lin M, Lechpammer M, Li C, Tanenbaum DM, Febbo PG et al. (2003). Cancer Res 63: 4781–4785.

  • Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C . (2004). Bioinformatics 20: 1233–1240.

  • Lindmark F, Zheng SL, Wiklund F, Balter KA, Sun J, Chang B et al. (2005). Br J Cancer 93: 493–497.

  • Livak KJ . (1999). Genet Anal 14: 143–149.

  • Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K . (1995). PCR Methods Appl 4: 357–362.

  • Loukola A, Chadha M, Penn SG, Rank D, Conti DV, Thompson D et al. (2004). Eur J Hum Genet 12: 321–332.

  • Maitra A, Arking DE, Shivapurkar N, Ikeda M, Stastny V, Kassauei K et al. (2005). Nat Genet 37: 1099–1103.

  • Maris JM, Hii G, Gelfand CA, Varde S, White PS, Rappaport E et al. (2005). Genome Res 15: 1168–1176.

  • Matsuzaki H, Loi H, Dong S, Tsai YY, Fang J, Law J et al. (2004). Genome Res 14: 414–425.

  • Metherell LA, Chapple JP, Cooray S, David A, Becker C, Ruschendorf F et al. (2005). Nat Genet 37: 166–170.

  • Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S et al. (2005). Nucleic Acids Res 33: D284–D288.

  • Middleton FA, Pato MT, Gentile KL, Morley CP, Zhao X, Eisener AF et al. (2004). Am J Hum Genet 74: 886–897.

  • Murray SS, Oliphant A, Shen R, McBride C, Steeke RJ, Shannon SG et al. (2004). Nat Methods 1: 113–117.

  • Nikiforov TT, Rendle RB, Goelet P, Rogers YH, Kotewicz ML, Anderson S et al. (1994). Nucleic Acids Res 22: 4167–4175.

  • Otterness D, Szumlanski C, Lennard L, Klemetsdal B, Aarbakke J, Park-Hah JO et al. (1997). Clin Pharmacol Ther 62: 60–73.

  • Ozaki K, Ohnishi Y, Iida A, Sekine A, Yamada R, Tsunoda T et al. (2002). Nat Genet 32: 650–654.

  • Packer BR, Yeager M, Staats B, Welch R, Crenshaw A, Kiley M et al. (2004). Nucleic Acids Res 32: D528–D532.

  • Puffenberger EG, Hu-Lince D, Parod JM, Craig DW, Dobrin SE, Conway AR et al. (2004). Proc Natl Acad Sci USA 101: 11689–11694.

  • Raghavan M, Lillington DM, Skoulakis S, Debernardi S, Chaplin T, Foot NJ et al. (2005). Cancer Res 65: 375–378.

  • Reumers J, Schymkowitz J, Ferkinghoff-Borg J, Stricher F, Serrano L, Rousseau F . (2005). Nucleic Acids Res 33: D527–D532.

  • Roshani L, Mallon P, Sjostrand E, Wedekind D, Szpirer J, Szpirer C et al. (2005). Cancer Genet Cytogenet 158: 137–141.

  • Saba TG, Montpetit A, Verner A, Rioux P, Hudson TJ, Drouin R et al. (2005). Hum Genet 116: 167–171.

  • Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A et al. (2005). Am J Hum Genet 77: 454–467.

  • Sawcer SJ, Maranian M, Singlehurst S, Yeo T, Compston A, Daly MJ et al. (2004). Hum Mol Genet 13: 1943–1949.

  • Schaid DJ, Guenther JC, Christensen GB, Hebbring S, Rosenow C, Hilker CA et al. (2004). Am J Hum Genet 75: 948–965.

  • Sellick GS, Garrett C, Houlston RS . (2003). Diabetes 52: 2636–2638.

  • Shen H, Xu Y, Zheng Y, Qian Y, Yu R, Qin Y et al. (2001). Int J Cancer 95: 332–336.

  • Shrimpton AE, Levinsohn EM, Yozawitz JM, Packard Jr DS, Cady RB, Middleton FA et al. (2004). Am J Hum Genet 75: 92–96.

  • Spielman RS, McGinnis RE, Ewens WJ . (1993). Am J Hum Genet 52: 506–516.

  • Spielman RS, McGinnis RE, Ewens WJ . (1994). Am J Hum Genet 54: 559–560 author reply 560-3.

  • Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M et al. (2005). Jama 293: 1485–1489.

  • Stephens LA, Powell NG, Grubb J, Jeremiah SJ, Bethel JA, Demidchik EP et al. (2005). Thyroid 15: 100–104.

  • Sun J, Wiklund F, Zheng SL, Chang B, Balter K, Li L et al. (2005). J Natl Cancer Inst 97: 525–532.

  • Teh MT, Blaydon D, Chaplin T, Foot NJ, Skoulakis S, Raghavan M et al. (2005). Cancer Res 65: 8597–8603.

  • Thompson ER, Herbert SC, Forrest SM, Campbell IG . (2005). Hum Mutat 26: 384–389.

  • Uhlenberg B, Schuelke M, Ruschendorf F, Ruf N, Kaindl AM, Henneke M et al. (2004). Am J Hum Genet 75: 251–260.

  • Ulvik A, Vollset SE, Hansen S, Gislefoss R, Jellum E, Ueland PM . (2004). Cancer Epidemiol Biomarkers Prev 13: 2175–2180.

  • Wong KK, Tsang YT, Shen J, Cheng RS, Chang YM, Man TK et al. (2004). Nucleic Acids Res 32: e69.

  • Yuan E, Li CM, Yamashiro DJ, Kandel J, Thaker H, Murty VV et al. (2005). Mol Cancer Res 3: 493–502.

  • Zhang L, Cui X, Schmitt K, Hubert R, Navidi W, Arnheim N . (1992). Proc Natl Acad Sci USA 89: 5847–5851.

  • Zhao X, Li C, Paez JG, Chin K, Janne PA, Chen TH et al. (2004). Cancer Res 64: 3060–3071.

  • Zhou X, Mok SC, Chen Z, Li Y, Wong DT . (2004). Hum Genet 115: 327–330.

Download references

Acknowledgements

JEL is funded by a grant from the CVS Corporation.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J E Landers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Engle, L., Simpson, C. & Landers, J. Using high-throughput SNP technologies to study cancer. Oncogene 25, 1594–1601 (2006). https://doi.org/10.1038/sj.onc.1209368

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209368

Keywords

This article is cited by

Search

Quick links